Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency
Antisense oligonucleotides are attractive therapeutic agents for several types of disease. One of the most promising modifications of antisense oligonucleotides is the introduction of bridged nucleic acids. As we report here, we designed novel bridged nucleic acids, triazole-bridged nucleic acid (Tr...
Saved in:
Published in | Journal of organic chemistry Vol. 82; no. 1; pp. 12 - 24 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
06.01.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Antisense oligonucleotides are attractive therapeutic agents for several types of disease. One of the most promising modifications of antisense oligonucleotides is the introduction of bridged nucleic acids. As we report here, we designed novel bridged nucleic acids, triazole-bridged nucleic acid (TrNA), and tetrazole-bridged nucleic acid (TeNA), whose sugar conformations are restricted to N-type by heteroaromatic ring-bridged structures. We then successfully synthesized TrNA and TeNA and introduced these monomers into oligonucleotides. In UV-melting experiments, TrNA-modified oligonucleotides exhibited increased binding affinity toward complementary RNA and decreased binding affinity toward complementary DNA, although TeNA-modified oligonucleotides were decomposed under the annealing conditions. Enzymatic degradation experiments demonstrated that introduction of TrNA at the 3′-terminus rendered oligonucleotides resistant to nuclease digestion. Furthermore, we tested the silencing potencies of TrNA-modified antisense oligonucleotides using in vitro and in vivo assays. These experiments revealed that TrNA-modified antisense oligonucleotides induced potent downregulation of gene expression in liver. In addition, TrNA-modified antisense oligonucleotides showed a tendency for increased liver biodistribution. Taken together, our findings indicate that TrNA is a good candidate for practical application in antisense methodology. |
---|---|
AbstractList | Antisense oligonucleotides are attractive therapeutic agents for several types of disease. One of the most promising modifications of antisense oligonucleotides is the introduction of bridged nucleic acids. As we report here, we designed novel bridged nucleic acids, triazole-bridged nucleic acid (TrNA), and tetrazole-bridged nucleic acid (TeNA), whose sugar conformations are restricted to N-type by heteroaromatic ring-bridged structures. We then successfully synthesized TrNA and TeNA and introduced these monomers into oligonucleotides. In UV-melting experiments, TrNA-modified oligonucleotides exhibited increased binding affinity toward complementary RNA and decreased binding affinity toward complementary DNA, although TeNA-modified oligonucleotides were decomposed under the annealing conditions. Enzymatic degradation experiments demonstrated that introduction of TrNA at the 3'-terminus rendered oligonucleotides resistant to nuclease digestion. Furthermore, we tested the silencing potencies of TrNA-modified antisense oligonucleotides using in vitro and in vivo assays. These experiments revealed that TrNA-modified antisense oligonucleotides induced potent downregulation of gene expression in liver. In addition, TrNA-modified antisense oligonucleotides showed a tendency for increased liver biodistribution. Taken together, our findings indicate that TrNA is a good candidate for practical application in antisense methodology. |
Author | Obika, Satoshi Sawamura, Motoki Wada, Fumito Hari, Yoshiyuki Fujimura, Yuko Waki, Reiko Noda, Mio Kugimiya, Akira Tahara, Saori Mitsuoka, Yasunori Yamamoto, Tsuyoshi Kato, Yuki |
AuthorAffiliation | Faculty of Pharmaceutical Sciences Discovery Research Laboratory for Innovative Frontier Medicines Research Laboratory for Development Tokushima Bunri University Osaka University Shionogi & Co., Ltd Graduate School of Pharmaceutical Sciences |
AuthorAffiliation_xml | – name: Discovery Research Laboratory for Innovative Frontier Medicines – name: Research Laboratory for Development – name: Tokushima Bunri University – name: Osaka University – name: Graduate School of Pharmaceutical Sciences – name: Faculty of Pharmaceutical Sciences – name: Shionogi & Co., Ltd |
Author_xml | – sequence: 1 givenname: Yasunori surname: Mitsuoka fullname: Mitsuoka, Yasunori – sequence: 2 givenname: Tsuyoshi surname: Yamamoto fullname: Yamamoto, Tsuyoshi – sequence: 3 givenname: Akira surname: Kugimiya fullname: Kugimiya, Akira email: akira.kugimiya@shionogi.co.jp – sequence: 4 givenname: Reiko surname: Waki fullname: Waki, Reiko – sequence: 5 givenname: Fumito surname: Wada fullname: Wada, Fumito – sequence: 6 givenname: Saori surname: Tahara fullname: Tahara, Saori – sequence: 7 givenname: Motoki surname: Sawamura fullname: Sawamura, Motoki – sequence: 8 givenname: Mio surname: Noda fullname: Noda, Mio – sequence: 9 givenname: Yuko surname: Fujimura fullname: Fujimura, Yuko – sequence: 10 givenname: Yuki surname: Kato fullname: Kato, Yuki – sequence: 11 givenname: Yoshiyuki surname: Hari fullname: Hari, Yoshiyuki – sequence: 12 givenname: Satoshi orcidid: 0000-0002-6842-6812 surname: Obika fullname: Obika, Satoshi email: obika@phs.osaka-u.ac.jp |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27936689$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUFv1DAQhS1URLelZ27IRyQ2W9uxnYTbUmipVLWoXbhGjj1pXWXtxXYQy1_gT9cl23JiLqMnfe9JM-8A7TnvAKE3lCwoYfRY6bi493ohO8I4rV6gGRWMFLIhfA_NCGGsKJks99FBjPckjxDiFdpnVVNKWTcz9GcVrPrtByiwcgavIIVJfgzW3ILBl6MewGq81NbED_hm69IdRBvn-NO4GeAXvkmqs4NN2_nEqgj4-pFIymmY_421Dn-3Kfh_4qfHS5dsBJfxrz6B09vX6GWvhghHu32Ivp1-Xp18KS6uzs5PlheFKpsmFX1JTGcohV5WNWdcCK4013WnmRFVRSot-7rnisiuEsyoqmMNU8awssxWxstD9G7K3QT_Y4SY2rWNGoZBOfBjbGktmBQNlyyjxxOqg48xQN9ugl2rsG0paR8baHMDbW6g3TWQHW934WO3BvPMP708A-8nYHKOweVb_xv3AAL4k_c |
CitedBy_id | crossref_primary_10_1021_acs_orglett_0c01780 crossref_primary_10_3390_biomedicines9060628 crossref_primary_10_1016_j_carres_2024_109126 crossref_primary_10_3390_molecules27238379 crossref_primary_10_1002_ejoc_202300946 crossref_primary_10_3762_bjoc_13_205 crossref_primary_10_1039_C7OB00698E crossref_primary_10_1016_j_tetlet_2020_151708 crossref_primary_10_1021_acs_joc_2c01582 crossref_primary_10_1002_ajoc_202000479 |
Cites_doi | 10.1016/S0040-4039(97)10322-7 10.1016/j.tetlet.2010.02.034 10.1039/b201557a 10.1021/jm801294h 10.1021/jo901009w 10.1016/S0040-4039(98)01084-3 10.1002/anie.201300555 10.1021/jo9814445 10.1016/j.ejphar.2013.11.004 10.1002/cbic.201200669 10.1002/cbic.201200506 10.1039/C4MD00184B 10.1016/S0960-894X(98)00366-7 10.1016/j.tetlet.2006.12.046 10.1039/9781849731102-00328 10.4155/fmc.11.2 10.1016/S0040-4020(98)00094-5 10.1002/cmdc.201000539 10.1002/anie.196306331 10.1039/c2cc32286b 10.1021/jm000209n 10.1016/0040-6031(89)85139-1 10.1007/s12265-013-9495-7 10.1107/S0567740879006567 10.1021/jo701914y 10.1021/jo902560f 10.1021/jo8016742 10.1021/ja038481k 10.1038/mtna.2012.16 10.1021/ja0177814 10.1021/ol902681t 10.1039/a708608c 10.1021/ja071106y 10.1161/01.ATV.0000066131.01313.EB 10.3987/REV-10-667 10.1039/C5OB00242G 10.1002/9783527621286.ch5 10.3791/3917 10.1021/jo801927k 10.1039/C3CC46017G 10.1021/bi0485732 10.1021/ol8003657 10.1021/ja105875e |
ContentType | Journal Article |
Copyright | Copyright © 2016 American Chemical Society |
Copyright_xml | – notice: Copyright © 2016 American Chemical Society |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1021/acs.joc.6b02417 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1520-6904 |
EndPage | 24 |
ExternalDocumentID | 10_1021_acs_joc_6b02417 27936689 a8803110 |
Genre | Journal Article |
GroupedDBID | - .K2 29L 53G 55A 5RE 5VS 7~N 85S AABXI ABFLS ABMVS ABPPZ ABPTK ABUCX ABUFD ACGFS ACJ ACNCT ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CJ0 CS3 D0L DU5 DZ EBS ED ED~ EJD F20 F5P GNL IH9 IHE JG JG~ K2 LG6 P2P PZZ ROL RXW TAE TN5 UI2 UKR UPT VF5 VG9 VQA W1F WH7 X XFK YZZ --- -DZ -~X 4.4 AAHBH ABJNI ABQRX ACBEA ACGFO ADHLV AGXLV AHGAQ CGR CUPRZ CUY CVF ECM EIF GGK IH2 NPM TAF XSW YQT ZCA AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-a399t-f30dbd11ef678424554ac4c8bc2d57707c6f8f4a06b752da7b292add233f30243 |
IEDL.DBID | ACS |
ISSN | 0022-3263 |
IngestDate | Fri Aug 16 10:29:23 EDT 2024 Fri Aug 23 03:28:48 EDT 2024 Sat Sep 28 07:59:38 EDT 2024 Thu Aug 27 13:42:11 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a399t-f30dbd11ef678424554ac4c8bc2d57707c6f8f4a06b752da7b292add233f30243 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6842-6812 |
PMID | 27936689 |
PQID | 1852659462 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1852659462 crossref_primary_10_1021_acs_joc_6b02417 pubmed_primary_27936689 acs_journals_10_1021_acs_joc_6b02417 |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 |
PublicationCentury | 2000 |
PublicationDate | 2017-01-06 |
PublicationDateYYYYMMDD | 2017-01-06 |
PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of organic chemistry |
PublicationTitleAlternate | J. Org. Chem |
PublicationYear | 2017 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | Schlingensiepen R. (ref3/cit3) 1997 ref9/cit9 ref45/cit45 ref6/cit6 ref36/cit36 ref27/cit27 ref18/cit18 ref11/cit11 ref25/cit25 ref16/cit16 ref29/cit29 ref32/cit32 ref23/cit23 ref39/cit39 ref14/cit14 ref8/cit8 ref5/cit5 ref31/cit31 ref43/cit43 Stein C. A. (ref2/cit2) 1998 ref34/cit34 ref37/cit37 ref28/cit28 ref40/cit40 ref20/cit20 ref17/cit17 ref10/cit10 ref26/cit26 ref35/cit35 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 ref42/cit42 ref46/cit46 ref41/cit41 ref22/cit22 ref13/cit13 ref33/cit33 ref4/cit4 ref30/cit30 ref1/cit1 ref24/cit24 ref38/cit38 ref44/cit44 ref7/cit7 |
References_xml | – ident: ref8/cit8 doi: 10.1016/S0040-4039(97)10322-7 – ident: ref29/cit29 doi: 10.1016/j.tetlet.2010.02.034 – ident: ref6/cit6 doi: 10.1039/b201557a – ident: ref17/cit17 doi: 10.1021/jm801294h – volume-title: Applied Antisense Oligonucleotide Technology year: 1998 ident: ref2/cit2 contributor: fullname: Stein C. A. – ident: ref15/cit15 doi: 10.1021/jo901009w – ident: ref9/cit9 doi: 10.1016/S0040-4039(98)01084-3 – ident: ref16/cit16 doi: 10.1002/anie.201300555 – ident: ref13/cit13 doi: 10.1021/jo9814445 – ident: ref33/cit33 doi: 10.1016/j.ejphar.2013.11.004 – volume-title: Antisense- from Technology to Therapy year: 1997 ident: ref3/cit3 contributor: fullname: Schlingensiepen R. – ident: ref22/cit22 doi: 10.1002/cbic.201200669 – ident: ref23/cit23 doi: 10.1002/cbic.201200506 – ident: ref5/cit5 doi: 10.1039/C4MD00184B – ident: ref14/cit14 doi: 10.1016/S0960-894X(98)00366-7 – ident: ref40/cit40 doi: 10.1016/j.tetlet.2006.12.046 – ident: ref25/cit25 doi: 10.1039/9781849731102-00328 – ident: ref4/cit4 doi: 10.4155/fmc.11.2 – ident: ref11/cit11 doi: 10.1016/S0040-4020(98)00094-5 – ident: ref27/cit27 doi: 10.1002/cmdc.201000539 – ident: ref37/cit37 doi: 10.1002/anie.196306331 – ident: ref34/cit34 – ident: ref42/cit42 doi: 10.1039/c2cc32286b – ident: ref26/cit26 doi: 10.1021/jm000209n – ident: ref41/cit41 doi: 10.1016/0040-6031(89)85139-1 – ident: ref1/cit1 doi: 10.1007/s12265-013-9495-7 – ident: ref31/cit31 doi: 10.1107/S0567740879006567 – ident: ref39/cit39 doi: 10.1021/jo701914y – ident: ref18/cit18 doi: 10.1021/jo902560f – ident: ref20/cit20 doi: 10.1021/jo8016742 – ident: ref28/cit28 doi: 10.1021/ja038481k – ident: ref46/cit46 doi: 10.1038/mtna.2012.16 – ident: ref35/cit35 doi: 10.1021/ja0177814 – ident: ref36/cit36 doi: 10.1021/ol902681t – ident: ref10/cit10 doi: 10.1039/a708608c – ident: ref19/cit19 doi: 10.1021/ja071106y – ident: ref32/cit32 doi: 10.1161/01.ATV.0000066131.01313.EB – ident: ref7/cit7 doi: 10.3987/REV-10-667 – ident: ref24/cit24 doi: 10.1039/C5OB00242G – ident: ref44/cit44 doi: 10.1002/9783527621286.ch5 – ident: ref45/cit45 doi: 10.3791/3917 – ident: ref30/cit30 doi: 10.1021/jo801927k – ident: ref43/cit43 doi: 10.1039/C3CC46017G – ident: ref12/cit12 doi: 10.1021/bi0485732 – ident: ref38/cit38 doi: 10.1021/ol8003657 – ident: ref21/cit21 doi: 10.1021/ja105875e |
SSID | ssj0000555 |
Score | 2.327149 |
Snippet | Antisense oligonucleotides are attractive therapeutic agents for several types of disease. One of the most promising modifications of antisense... |
SourceID | proquest crossref pubmed acs |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 12 |
SubjectTerms | Deoxyribonucleases - chemistry Deoxyribonucleases - metabolism DNA, Complementary - chemistry Humans Nucleic Acid Conformation Nucleic Acids - chemical synthesis Nucleic Acids - chemistry Oligonucleotides, Antisense - chemistry RNA, Complementary - chemistry Tetrazoles - chemical synthesis Tetrazoles - chemistry |
Title | Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency |
URI | http://dx.doi.org/10.1021/acs.joc.6b02417 https://www.ncbi.nlm.nih.gov/pubmed/27936689 https://search.proquest.com/docview/1852659462 |
Volume | 82 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELYoHNpLeZSWLQ-5EoceNtvE8SPmtiwghFSEyoK4RY7tSCnIQZts1eUv8KcZJ_tQixAcE00mlj3298XjfIPQPpEiYkaEQaK4DmhiZSBDamAxhC8xQCzAOL818POcn17Rsxt2sxCL_j-DT6IfSle936Xu8QzgJBLv0AoRMDU8CxpcLhZdxthcGJzweK7i88yBhyFd_QtDL3DLBmNOVtvTWVUjTeiPltz2xnXW0w_PhRtfb_4a-jhlmrjfhsY6WrJuA70fzAq8fUKPQwi-h_LOBlg5g4e2HrWXh81PXAafe63jQuO-Lkx1gC8nDthiVVRdfDS-v7N_MTDV5mztpNvaAiLiX96i9rHUbdwWDl8X9ahcXPwpcd_5GtAOzC9KT9onm-jq5Hg4OA2mtRkCBZSmDvI4NJmJIpsD2vnsKaNKU51kmhgmRCg0z5OcqpBnghGjREYkgbWUxDE8Smj8GS270tkthEOWZ0RI4H7G0jAx0kpJ8zBWEYcXaNFB-9CJ6XRuVWmTNidR2t7U6bRnO-j7bETT-1ap42XTb7MRT6HPfYpEOVuOwXfiywVIykkHfWlDYe4M2hhznsivb2vPNvpAPAXw2zV8By3Xo7HdBQJTZ3tN6D4B3pXpGg |
link.rule.ids | 315,783,787,2772,27088,27936,27937,57066,57116 |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VcigXKO-FAkbqgcNmSRw_4t6WhWqBdgV0i3qLEtuRApVTbbKI7V_gT3ec7EOAKsEx1mQysSf-vnjsGYB9qmTEjQyDJBM6YIlVgQqZwckQ_8QQsRDj_NLA8USMT9mHM362BeHqLAwaUaOmug3ib7ILRK9927dKD0SOqBLJG3CTS4RLT4ZGJ5u5l3O-zg9ORbxO5vOXAo9Guv4dja6hmC3UHN6Bz2sj2x0m3wfzJh_oyz_yN_7PW-zC7SXvJMPOUe7ClnX3YGe0Kvd2H35N0RUvq3MbkMwZMrXNrLt80x7pMmTiMx-Xmgx1aeoDcrJwyB3rsu6Tt_OLc_uTIG9td9ou-p0s4iP54iUa71n9Vm3pyNeymVWbix8VGTpfEdqh-KfKU_jFAzg9fDcdjYNlpYYgQ4LTBEUcmtxEkS0Q-3wslbNMM53kmhouZSi1KJKCZaHIJacmkzlVFGdWGsd4K2XxQ9h2lbOPgYS8yKlUyASNZWFilFWKFWGcRQIfoGUP9rET0-WXVqdtEJ1Gadeo02XP9uDVamDTiy5vx_WiL1cDn2Kf-4BJ5mw1R92JLx6gmKA9eNR5xFoZ2hgLkagn_2bPC9gZT4-P0qP3k49P4Rb15MAv5Ig92G5mc_sMqU2TP2-9-QpoA_F_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbGJgEvsHEtMDDSHnhoSuL4EvNWulUbl2piLdpblNiOFJicqkkR3V_gT3PspJ0GmgSPtk5OHPvY3xcf-xyEDogUEdMiDJKMq4AmRgYypBoWQ_gTA8QCjHNbA58n_HhGP5yz8-5SmLsLA42oQVPtnfhuVs910UUYiN66-m-VGvAckCUSt9AOE5F3zg5HZ1frL2NsEyOc8HgT0OcvBQ6RVH0dkW6gmR5uxvfRbNNQf8rk-2DZ5AN1-UcMx__9kl10r-OfeNgazB7aMvYBujNap317iH5NwSQvqwsT4MxqPDXNoi2-91e7NJ64CMilwkNV6vodPltZ4JB1Wffx4XJ-YX5i4K_-xO2q38oCTuIvTqJxFtb3akuLv5bNoroq_Kjw0LrM0BbETytH5VeP0Gx8NB0dB13GhiADotMERRzqXEeRKQADnU-V0UxRleSKaCZEKBQvkoJmIc8FIzoTOZEEVlgSx_AoofFjtG0ra54iHLIiJ0ICI9SGhomWRkpahHEWcXiBEj10AJ2YdjOuTr0znURpW6nSrmd76M16cNN5G7_jZtHX68FPoc-d4ySzplqC7sQlEZCUkx560lrFRhm0MeY8kc_-rT2v0O3Tw3H66WTy8Tm6SxxHcPs5_AXabhZLsw8Mp8lfeoP-DTL68_k |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Triazole-+and+Tetrazole-Bridged+Nucleic+Acids%3A+Synthesis%2C+Duplex+Stability%2C+Nuclease+Resistance%2C+and+in+Vitro+and+in+Vivo+Antisense+Potency&rft.jtitle=Journal+of+organic+chemistry&rft.au=Mitsuoka%2C+Yasunori&rft.au=Yamamoto%2C+Tsuyoshi&rft.au=Kugimiya%2C+Akira&rft.au=Waki%2C+Reiko&rft.date=2017-01-06&rft.pub=American+Chemical+Society&rft.issn=0022-3263&rft.eissn=1520-6904&rft.volume=82&rft.issue=1&rft.spage=12&rft.epage=24&rft_id=info:doi/10.1021%2Facs.joc.6b02417&rft.externalDocID=a8803110 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3263&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3263&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3263&client=summon |